GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » Pre-Tax Income

Heidelberg Pharma AG (XTER:HPHA) Pre-Tax Income : €-13.24 Mil (TTM As of May. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Heidelberg Pharma AG's pretax income for the three months ended in May. 2024 was €-4.22 Mil. Its pretax income for the trailing twelve months (TTM) ended in May. 2024 was €-13.24 Mil. Heidelberg Pharma AG's pretax margin was -151.36%.

During the past 13 years, Heidelberg Pharma AG's highest Pretax Margin was -96.07%. The lowest was -1493.66%. And the median was -250.81%.


Heidelberg Pharma AG Pre-Tax Income Historical Data

The historical data trend for Heidelberg Pharma AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG Pre-Tax Income Chart

Heidelberg Pharma AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.14 -18.37 -26.14 -17.79 -20.35

Heidelberg Pharma AG Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.29 0.21 -4.79 -4.45 -4.22

Competitive Comparison of Heidelberg Pharma AG's Pre-Tax Income

For the Biotechnology subindustry, Heidelberg Pharma AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heidelberg Pharma AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Pre-Tax Income falls into.



Heidelberg Pharma AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Heidelberg Pharma AG's Pretax Income for the fiscal year that ended in Nov. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.097+0+-0.762+1.625+6.888
=-20.35

Heidelberg Pharma AG's Pretax Income for the quarter that ended in May. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.196+0+-0.037+0.379+1.634
=-4.22

Pre-Tax Income for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-13.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heidelberg Pharma AG  (XTER:HPHA) Pre-Tax Income Explanation

Heidelberg Pharma AG's Pretax Margin for the quarter that ended in May. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-4.22/2.788
=-151.36%

During the past 13 years, Heidelberg Pharma AG's highest Pretax Margin was -96.07%. The lowest was -1493.66%. And the median was -250.81%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heidelberg Pharma AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Heidelberg Pharma AG Business Description

Traded in Other Exchanges
Address
Gregor-Mendel-Street 22, Ladenburg, DEU, 68526
Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.
Executives
Prof. Dr. Andreas Pahl Board of Directors

Heidelberg Pharma AG Headlines

No Headlines